Pharma Mar SA Financial Overview
Pharma Mar SA's market cap is currently €1.36B. The company's EPS TTM is €-0.13; its P/E ratio is 39.50; and it has a dividend yield of 1.05%. Pharma Mar SA is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is €1.51. See an overview of income statement, balance sheet, and cash flow financials.
